组织细胞肉瘤的FNA细胞形态学与分子特征新见解
该研究回顾了6例组织细胞肉瘤患者的8份FNA样本,结合免疫组化和靶向外显子NGS分析,发现肿瘤细胞呈多形性上皮样、双核或多核,伴炎症背景,常表达CD68、CD163和PU.1,部分病例存在KMT2D/MLL2基因改变。单独FNA诊断困难,但特定形态学提示应使用组织细胞标志物确认。
要点
- FNA涂片见多形性上皮样大细胞、双核/多核及炎症背景时应警惕组织细胞肉瘤。
- 免疫组化CD68、CD163和PU.1有助于确认组织细胞分化。
- 部分病例检测到KMT2D/MLL2改变,提示表观遗传调控参与发病。
核心结论
- FNA诊断组织细胞肉瘤极具挑战,但多形性上皮样大细胞伴双核/多核及炎症背景应提示本病。
- 检测到复发性KMT2D/MLL2改变提示表观遗传调控参与组织细胞肉瘤发病。
研究设计与样本
- 回顾性病例系列,纳入6例患者的8份FNA样本,并复习组织病理和临床资料。
- 对3例细胞块、5例粗针活检和4例手术标本进行免疫组化。
- 对4例手术切除标本进行靶向外显子NGS。
主要发现
- 4例患者有已知的血液淋巴系统恶性肿瘤病史。
- 细胞形态包括大上皮样细胞、肾形核、丰富空泡状胞质,炎症背景,偶见噬血现象和淋巴腺小体。
- 常见显著多形性、多核巨细胞及双核组织细胞样细胞,核偏位部分重叠呈「吃豆人」样。
- 免疫组化表达:CD68(6/7例)、CD163(5/5例)、PU.1(3/4例)。
- 3例NGS发现KMT2D/MLL2基因改变。
关键数值与推荐
- CD68阳性6/7例,CD163阳性5/5例,PU.1阳性3/4例。
- 3例检出KMT2D/MLL2改变。
临床怎么用
- FNA见多形性上皮样大细胞、双核/多核及炎症背景时,应使用组织细胞标志物(CD68、CD163、PU.1)确认。
- 单独FNA诊断困难,需结合免疫组化和分子检测。
局限性
- 样本量小(6例患者,8份FNA)。
- 免疫组化病例数不全(CD68 7例、CD163 5例、PU.1 4例)。
- NGS仅4例手术标本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Histiocytic sarcoma (HS) is a rare malignant neoplasm showing morphologic and immunophenotypic features of histiocytes. Molecular characteristics of HS and fine-needle aspiration (FNA) criteria for its diagnosis have not been established. METHODS: A case series of HS in 8 FNA samples from 6 patients was reviewed along with histopathologic and clinical data. Immunohistochemistry was performed on cell blocks (3 cases), core biopsies (5 cases), and surgical specimens (4 cases). Targeted-exome next-generation sequencing (NGS) was performed on surgical resection specimens in 4 cases. RESULTS: Four patients had a known history of hematolymphoid malignancy. Cytomorphologic features included variably cellular smears composed of large epithelioid cells with reniform nuclei and abundant vacuolated cytoplasm, in an inflammatory background, with occasional cytophagocytosis and lymphoglandular bodies. Marked pleomorphism, multinucleated monster cells, and binucleated histiocytoid cells with partially overlapping, eccentrically placed nuclei resembling Pac-Man were common. Most cases expressed histiocytic markers CD68 (6 of 7 cases), CD163 (5 of 5 cases), and PU.1 (3 of 4 cases). In 3 cases, NGS analysis revealed alterations in lysine methyltransferase 2D (KMT2D)/mixed-lineage leukemia 2 (MLL2), a gene involved in chromatin regulation and previously implicated in the pathogenesis of follicular lymphoma. CONCLUSIONS: Although diagnosing HS with FNA alone is extremely challenging, the presence of pleomorphic and epithelioid large cells with binucleation and/or multinucleation in an inflammatory background should prompt the diagnosis of HS with judicious use of confirmatory histiocytic lineage markers. The detection of recurrent KMT2D/MLL2 alterations implicates epigenetic regulation in the pathogenesis of HS and supports the notion of transdifferentiation from a genetically similar but phenotypically distinct tumor of a different lineage. Cancer Cytopathol 2017;125:604-14. © 2017 American Cancer Society.
引用
- Hung YP, Lovitch SB, Qian X, et al. Histiocytic sarcoma: New insights into FNA cytomorphology and molecular characteristics. Cancer Cytopathol. 2017. PMID: 28805986. doi:10.1002/cncy.21851
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。